NASDAQ:KARD Kardigan Q2 2026 Earnings Report $14.66 -0.12 (-0.81%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast Kardigan EPS ResultsActual EPS-$4.61Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AKardigan Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AKardigan Announcement DetailsQuarterQ2 2026Date8/11/2026TimeBefore Market OpensConference Call DateTuesday, August 11, 2026Conference Call Time7:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Kardigan Earnings HeadlinesKardigan: Funded Precision Cardiology Offers More Than Pipeline DiversificationSeptember 13, 2026 | seekingalpha.comKardigan to Present at Two September Investor ConferencesSeptember 2, 2026 | businesswire.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.September 29 at 1:00 AM | Profits Run (Ad)Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ RadarSeptember 2, 2026 | tipranks.comKardigan Inc (KARD) Stock Price, Quote, News & HistoryAugust 20, 2026 | benzinga.comWe've developed a first-of-its-kind medicine to battle cardiovascular disease: Kardigan CEOJune 26, 2026 | msn.comSee More Kardigan Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Kardigan? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kardigan and other key companies, straight to your email. Email Address About KardiganKardigan (NASDAQ:KARD) is a biopharmaceutical company focused on developing therapies for cardiovascular and related serious diseases. Its activities center on the discovery and clinical development of innovative medicines intended to address significant unmet medical needs. The company operates as a research- and development-stage business, with its principal activities involving drug discovery, preclinical research, clinical testing and potential commercialization of pharmaceutical products. Publicly available information about Kardigan’s specific product portfolio and development programs is limited. Detailed information about Kardigan’s corporate history, geographic operations and leadership was not available from reliable sources.View Kardigan ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
